leadf
logo-loader
viewTissue Regenix Group PLC

No evidence of data breach from cyber attack says Tissue Regenix

Any associated costs of the system restoration are unlikely to be material to short-term cash flow

Tissue Regenix Group PLC -
Tissue has upgraded its systems since the attack

Tissue Regenix Group (LON:TRX) has restored all critical IT systems at its US facility after a recent cyber attack with no evidence any critical or personal data was stolen.

There has been some short-term disruption, but delayed orders will be dispatched over the coming weeks said the med-tech.

Any associated costs of the system restoration are unlikely to be material to short-term cash flow while additional security measures now implemented should reduce the risk of a recurrence, it said.

Quick facts: Tissue Regenix Group PLC

Price: 0.361 GBX

AIM:TRX
Market: AIM
Market Cap: £25.39 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Tissue Regenix "advancing on many fronts" says CEO after SurgiPure FDA clearance

Antony Odell, chief executive at Tissue Regenix (LON:TRX), talks to Proactive Investors about the US FDA clearance for SurgiPure XD, a skin graft for hernias derived from pig tissue. The group, which already has experience of commercialising products in the US, is planning a commercial...

on 03/09/2016

2 min read